ImmunoGuide® Enzyme immunoassay (ELISA) for the specific determination of free Ranibizumab in aqueous humor.<br><br>
The drug Ranibizumab (trade name Lucentis®) is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment (Fab) designed for intraocular use. Ranibizumab binds to and inhibits the biologic activity of human vascular endothelial growth factor A (VEGF-A). Ranibizumab, which lacks an Fc region, has a molecular weight of approximately 48 kilodaltons.<br><br>
The ImmunoGuide Ranibizumab ELISA (mAb-based) kit can be efficiently used for measuring free Ustekinumab levels in aqueous humor. For research use only, not for use in diagnostic procedures.
- Assay Description:
- 1 hour incubation (RT) + 30 min. (RT) + 30 min. (RT) + 15 min. (RT) = 2 hour, 15 min. total incubation time
- Catalog number:
- TM09034
- configuration:
- 96 Determinations, 12x8 removable strips.
- controls:
- None provided
- design:
- Enzyme immunoassay (ELISA) technique
- FDA Status:
- For research use only, not for use in diagnostic procedures
- MSDS:
- Available upon request
- notes:
- The protocol for this product (see above) is intended to serve as an example only. Please refer to the Instructions For Use provided with the assay kit for precise details.
- Other names:
- Lucentis®
- Protocol:
- Sample types:
- Aqueous humor
- Sample volume:
- 5 µL
- standards:
- 5 standards, dilute 1:10 prior to use
- Standard range:
- 0 / 10 - 300 ng/mL
- storage:
- 2 - 8 °C
- sensitivity:
- 0.33 ng/mL
- Species:
- Human
- Additional info:
